COF
63
-4
VZ
42
3
KSS
42
-3
DTE
38
-4
SYF
93
-2
ADI
45
-5
PNR
74
5
AES
41
2
PDCO
30
-6
CHRW
67
3
CF
53
2
CNP
50
-2
NWS
79
-4
AVY
53
2
LRCX
46
-2
CSX
68
3
GLW
48
-5
MLM
57
-3
TAP
64
4
DRI
56
2
COF
63
-4
VZ
42
3
KSS
42
-3
DTE
38
-4
SYF
93
-2
ADI
45
-5
PNR
74
5
AES
41
2
PDCO
30
-6
CHRW
67
3
CF
53
2
CNP
50
-2
NWS
79
-4
AVY
53
2
LRCX
46
-2
CSX
68
3
GLW
48
-5
MLM
57
-3
TAP
64
4
DRI
56
2
Financhill
Back

Moleculin Biotech Vs. Citius Pharmaceuticals Industry Stock Comparison

Sell
36

MBRX
Moleculin Biotech

Last Price:
3.09
Seasonality Move:
-0.2%
Sell
46

CTXR
Citius Pharmaceuticals

Last Price:
0.33
Seasonality Move:
21.66%
Sell
36
Moleculin Biotech (MBRX) is a Sell

Is Moleculin Biotech a Buy, Sell or Hold?

  • The current Moleculin Biotech [MBRX] share price is $2.50. The Score for MBRX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • MBRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Citius Pharmaceuticals (CTXR) is a Sell

Is Citius Pharmaceuticals a Buy, Sell or Hold?

  • The current Citius Pharmaceuticals [CTXR] share price is $0.39. The Score for CTXR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • CTXR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MBRX Stock Price Chart

What is Moleculin Biotech's stock price today?

  • The Moleculin Biotech share price today is $2.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MBRX is experiencing selling pressure, which indicates risk of future bearish movement.

CTXR Stock Price Chart

What is Citius Pharmaceuticals's stock price today?

  • The Citius Pharmaceuticals share price today is $0.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing selling pressure, which indicates risk of future bearish movement.

MBRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 49.66 Sell
Chaikin Money Flow: -29938 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.4 - 2.6) Sell
Bollinger Bands (100): (2.21 - 3.39) Sell

CTXR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 46.64 Sell
Chaikin Money Flow: -1938218 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.35 - 0.41) Buy
Bollinger Bands (100): (0.4 - 0.76) Sell

MBRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.47 Buy
20-day SMA: 2.52 Sell
50-day SMA: 2.5 Buy
200-day SMA: 4.43 Sell
8-day EMA: 2.51 Sell
20-day EMA: 2.51 Sell
50-day EMA: 2.58 Sell
200-day EMA: 4.4 Sell

CTXR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.39 Sell
20-day SMA: 0.38 Buy
50-day SMA: 0.44 Sell
200-day SMA: 0.65 Sell
8-day EMA: 0.41 Sell
20-day EMA: 0.4 Sell
50-day EMA: 0.45 Sell
200-day EMA: 0.63 Sell

Moleculin Biotech Earnings Growth & MBRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.06 per share, and an increase next year of $8.81 per share.

Citius Pharmaceuticals Earnings Growth & CTXR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.

Moleculin Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Citius Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):